We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-4.19%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.1B
AUM Growth
-$4.09B
(-14%)
Cap. Flow
-$2.77B
Cap. Flow
% of AUM
-10.63%
Top 10 Holdings %
Top 10 Hldgs %
22.95%
Holding
1,846
New
56
Increased
388
Reduced
1,301
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$49.4M |
| 2 |
Nucor
NUE
|
+$35.6M |
| 3 |
Essex Property Trust
ESS
|
+$27.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$27.3M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$21.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$366M |
| 2 |
Microsoft
MSFT
|
+$279M |
| 3 |
Amazon
AMZN
|
+$213M |
| 4 |
Tesla
TSLA
|
+$109M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.74% |
| 2 | Consumer Staples | 11.79% |
| 3 | Consumer Discretionary | 11.57% |
| 4 | Industrials | 10.74% |
| 5 | Healthcare | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
SunCoke Energy
SXC
$757M
| $66K | ﹤0.01% |
11,457
-295
| -3% | -$1.98K |
|
|
SRNE
1627
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $66K | ﹤0.01% |
41,911
-801
| -2% | -$1.82K |
|
|
BRSP
1628
BrightSpire Capital
BRSP
$681M
| $65K | ﹤0.01% |
10,330
-371
| -3% | -$3.06K |
|
|
BBBY
1629
DELISTED
Bed Bath & Beyond Inc
BBBY
| $65K | ﹤0.01% |
10,679
-564
| -5% | -$4.59K |
|
|
AGEN
1630
Agenus
AGEN
$249M
| $64K | ﹤0.01% |
1,589
+43
| +3% | +$2.19K |
|
1631
Oscar Health
OSCR
$8.5B
| $64K | ﹤0.01% |
13,023
-249
| -2% | -$1.45K |
|
|
NVTA
1632
DELISTED
Invitae Corporation
NVTA
| $64K | ﹤0.01% |
26,036
-3,282
| -11% | -$9.96K |
|
|
CTIC
1633
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $64K | ﹤0.01% |
11,038
+633
| +6% | +$3.94K |
|
|
VMEO
1634
DELISTED
Vimeo
VMEO
| $63K | ﹤0.01% |
15,783
-6,166
| -28% | -$36.5K |
|
|
AMRS
1635
DELISTED
Amyris Inc.
AMRS
| $63K | ﹤0.01% |
21,704
-413
| -2% | -$1.13K |
|
1636
Conduent
CNDT
$230M
| $62K | ﹤0.01% |
18,715
-358
| -2% | -$1.49K |
|
1637
Ocular Therapeutix
OCUL
$1.86B
| $62K | ﹤0.01% |
14,986
+353
| +2% | +$1.78K |
|
1638
Precigen
PGEN
$1.93B
| $61K | ﹤0.01% |
28,637
+1,124
| +4% | +$2.37K |
|
1639
SiriusPoint
SPNT
$2.98B
| $61K | ﹤0.01% |
12,471
-361
| -3% | -$1.68K |
|
1640
W&T Offshore
WTI
$545M
| $61K | ﹤0.01% |
10,421
-199
| -2% | -$1.09K |
|
|
SHCR
1641
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $61K | ﹤0.01% |
+32,455
| New | +$56.9K |
|
|
PRVB
1642
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $61K | ﹤0.01% |
13,357
+2,082
| +18% | +$9.49K |
|
1643
Bionano Genomics
BNGO
$12.7M
| $59K | ﹤0.01% |
54
-1
| -2% | -$1.32K |
|
1644
Lexicon Pharmaceuticals
LXRX
$1.02B
| $59K | ﹤0.01% |
24,625
+4,793
| +24% | +$13.3K |
|
1645
Nordic American Tanker
NAT
$1.37B
| $59K | ﹤0.01% |
21,858
+491
| +2% | +$1.3K |
|
|
ORGN
1646
DELISTED
Origin Materials
ORGN
| $59K | ﹤0.01% |
386
-12
| -3% | -$2.13K |
|
|
RBOT
1647
DELISTED
Vicarious Surgical
RBOT
| $59K | ﹤0.01% |
585
+36
| +7% | +$4.19K |
|
|
VRAY
1648
DELISTED
ViewRay, Inc.
VRAY
| $59K | ﹤0.01% |
16,322
-310
| -2% | -$1.04K |
|
|
AFMD
1649
DELISTED
Affimed
AFMD
| $58K | ﹤0.01% |
2,824
+64
| +2% | +$1.78K |
|
1650
AvePoint
AVPT
$2.6B
| $57K | ﹤0.01% |
14,199
-270
| -2% | -$1.27K |
|
Similar funds
ProShare Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, ProShare Advisors held 1,846 positions worth $26.1B, down 14% from $30.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
ProShare Advisors withdrew a net $2.77B in Q3 2022, closing 96 positions and reducing 1,301 holdings. Its most notable exit was Neenah, Inc. Common Stock, an estimated $7.52M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, ProShare Advisors opened a new position in Xometry worth $7.31M.
- ProShare Advisors's largest Q3 2022 buy was Xometry: 128,758 shares worth $7.31M.
- ProShare Advisors added most to Target in Q3 2022, an estimated $49.4M increase.
- ProShare Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $366M.
- ProShare Advisors fully exited Neenah, Inc. Common Stock in Q3 2022, selling an estimated $7.52M.
- ProShare Advisors's ten largest holdings make up 23% of its $26.1B portfolio in Q3 2022.
- ProShare Advisors opened 56 new positions and closed 96 in Q3 2022.
- ProShare Advisors's portfolio value fell 14% quarter-over-quarter to $26.1B.
Based on ProShare Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.